Home / HealthHealthJapan TimesHealthJapan Times·Jul 22, 2026·1 min readAnother iPS product approved for public insurance coverage in JapanIt is the second case of insurance coverage approval in the nation for an induced pluripotent stem cell-derived regenerative medicine product.View original source — Japan Times ↗ShareCopy linkShare on XShare on FacebookRelated storiesHealthABC NewsHealthSep 17, 2026 · 1 minCallers told no ambulances available almost 17,000 times in TasmaniaABC NewsHealthBBCHealthSep 17, 2026 · 1 minMore than 1,000 children killed in Bangladesh measles outbreakBBCHealthTimes of IndiaHealthSep 17, 2026 · 1 minAnother Gurgaon shocker: 2 killed, 2 critical as DU student’s speeding car mows down 4Times of IndiaHealthPhilippine Daily InquirerHealthSep 17, 2026 · 1 minSouth Korea to allow abortion pills for pregnancies of up to 9 weeksPhilippine Daily Inquirer
HealthABC NewsHealthSep 17, 2026 · 1 minCallers told no ambulances available almost 17,000 times in TasmaniaABC News
HealthTimes of IndiaHealthSep 17, 2026 · 1 minAnother Gurgaon shocker: 2 killed, 2 critical as DU student’s speeding car mows down 4Times of India
HealthPhilippine Daily InquirerHealthSep 17, 2026 · 1 minSouth Korea to allow abortion pills for pregnancies of up to 9 weeksPhilippine Daily Inquirer